Country’s Leading Public Relations Agency (IMPRIMIS PR) to Provide Integrated Communications Solutions to the Organization of Pharmaceuticals Producers of India (OPPI).
Lees meer..

Chronic hepatitis B can now be treated with a new drug.
Chronic hepatitis B can now be treated with a new drug.
Lees meer..

Because secondary hypertension can most often be linked to certain conditions and medications,
treatment strategies focus on identifying and removing the pathologic or pharmacologic cause in order to restore
normal hemostatic homeostasis and blood pressure control.
Because secondary hypertension can most often be linked to certain conditions and medications,
treatment strategies focus on identifying and removing the pathologic or pharmacologic cause in order to restore
normal hemostatic homeostasis and blood pressure control.
Lees meer..

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the malignant melanoma drug market, driven by the launch of emerging agents, will experience robust annual 12 percent growth through 2012 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Lees meer..

A Bionovo Inc. drug aimed at menopausal hot flashes helped women sleep better, too, the company said Monday. (BNVI)

Lees meer..

Enanta Pharmaceuticals Inc. has launched a human clinical trial to test an antibiotic against drug-resistant infections.

Lees meer..

The University of Kansas will be awarded $20.2 million to participate in a federal program aimed at identifying small molecules for use as probes to investigate the diverse functions of cells.

Lees meer..

Cardica Inc. said Monday it received a $1 million milestone payment from Cook Medical for the successful development of a specialized automated device used to close holes in the heart. (CRDC)

Lees meer..

Model N, the leader in Revenue Management solutions, announced it will leverage its expertise on post-DRA operational best practices to deliver a hands-on exhibit and presentations at IIR’s 13th Annual Medicaid Drug Rebate Program Conference this week in Chicago.
Lees meer..

FDA has approved Stavzor, delayed-release soft gelatin capsules of valproic acid, for the treatment of
bipolar disorder.
FDA has approved Stavzor, delayed-release soft gelatin capsules of valproic acid, for the treatment of
bipolar disorder.
Lees meer..